What is the recommended assessment and management of an adult presenting with acute watery diarrhea, including evaluation for red‑flag features, rehydration strategy, antimicrobial indications, and symptomatic therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Approach to Acute Watery Diarrhea in Adults

Begin immediate oral rehydration with reduced-osmolarity ORS (65-70 mEq/L sodium) as the cornerstone of therapy; empiric antibiotics are not indicated for uncomplicated watery diarrhea in immunocompetent adults without recent international travel. 1, 2

Immediate Assessment for Red-Flag Features

Evaluate every patient for the following high-risk features that change management:

Features Requiring Stool Testing and Possible Antibiotics

  • Fever (≥38.5°C) with bloody or mucoid stools – suggests invasive bacterial pathogens (Shigella, Campylobacter, invasive E. coli) requiring empiric antibiotics 1, 3
  • Recent international travel with severe symptoms – travelers' diarrhea warrants empiric antibiotics to reduce duration from 50-93 hours to 16-30 hours 3, 4
  • Signs of sepsis (altered mental status, hypotension, tachycardia) – requires blood cultures and empiric broad-spectrum antibiotics 1
  • Immunocompromised status with severe illness – lower threshold for antibiotics and diagnostic workup 1, 3
  • Infants <3 months of age – require blood cultures and empiric third-generation cephalosporin 1

Features Requiring Immediate Stool Testing (BEFORE Antibiotics)

  • Bloody diarrhea without fever – must rule out STEC O157:H7 and other Shiga toxin-producing E. coli before any antibiotics, as antibiotics markedly increase risk of hemolytic uremic syndrome 1, 3
  • Severe abdominal cramping or tenderness – obtain Shiga toxin testing 1

Features Indicating Severe Dehydration (Requires IV Fluids)

  • Altered mental status 1, 2
  • Inability to tolerate oral intake 1, 2
  • Prolonged skin tenting (>2 seconds) 2
  • Cool extremities with decreased capillary refill 2
  • Hypotension or shock 1, 2

Rehydration Strategy (All Patients)

Mild to Moderate Dehydration (First-Line)

  • Prescribe reduced-osmolarity ORS containing 65-70 mEq/L sodium and 75-90 mmol/L glucose 1, 2
  • Total daily fluid intake: 2,200-4,000 mL/day, exceeding ongoing losses (urine + 30-50 mL/hour insensible losses + stool volume) 2
  • Replace each watery stool with 10 mL/kg of ORS 5
  • Continue ORS until clinical dehydration resolves and diarrhea stops 1, 2

Severe Dehydration (Switch to IV)

  • Administer isotonic IV fluids (lactated Ringer's or normal saline) immediately for severe dehydration, shock, altered mental status, or failure of oral rehydration 1, 2
  • Continue IV rehydration until pulse, perfusion, and mental status normalize, then transition to ORS for remaining deficit 1, 2

Antimicrobial Indications (Specific Scenarios Only)

DO NOT Give Antibiotics If:

  • Uncomplicated watery diarrhea without fever, blood, or travel history – strong recommendation against empiric antibiotics 1, 3, 2
  • Suspected or confirmed STEC O157:H7 or Shiga toxin 2-producing E. coli – antibiotics increase hemolytic uremic syndrome risk 1, 3
  • Asymptomatic contacts of patients with diarrhea 1, 3

DO Give Empiric Antibiotics If:

  • Fever with bloody diarrhea (bacillary dysentery) – presumptive Shigella 1, 3
  • Recent international travel with fever ≥38.5°C or signs of sepsis 3
  • Suspected enteric fever with sepsis features – after obtaining blood, stool, and urine cultures 1, 3
  • Immunocompromised with severe illness and bloody diarrhea 1, 3

Antibiotic Selection When Indicated

  • First-line: Azithromycin 3, 4

    • Acute watery diarrhea: 500 mg single dose 3, 4
    • Febrile diarrhea/dysentery: 1,000 mg single dose 3, 4
    • Preferred due to >90% fluoroquinolone resistance in Campylobacter in many regions (Thailand, India) 3
  • Second-line: Fluoroquinolones (only if azithromycin unavailable or local susceptibility favorable) 3

    • Ciprofloxacin: 750 mg single dose or 500 mg twice daily for 3 days 3, 4
    • Levofloxacin: 500 mg single dose or once daily for 3 days 3, 4
  • Pediatric (<3 months with suspected bacterial etiology): Third-generation cephalosporin (ceftriaxone 50 mg/kg/day) 1, 3

Symptomatic Therapy (After Adequate Rehydration)

Antimotility Agents

  • Loperamide may be used in immunocompetent adults with watery diarrhea once adequately hydrated 1, 2
    • Initial dose: 4 mg, then 2 mg after each loose stool (maximum 16 mg/24 hours) 2
    • Contraindicated if fever or bloody stools present – risk of toxic megacolon 1, 2
    • Never use in children <18 years 1

Dietary Management

  • Resume normal, age-appropriate diet immediately after rehydration 1, 2
  • Small, light meals initially, avoiding fatty, heavy, spicy foods and caffeine 2, 5

Adjunctive Therapies

  • Antiemetics (ondansetron) may be considered after adequate rehydration, but do not replace fluid therapy 2
  • Probiotics may reduce symptom severity and duration (weak recommendation) 2

Diagnostic Testing (Selective, Not Routine)

Obtain Stool Studies If:

  • Fever with bloody or mucoid stools 1
  • Severe dehydration or illness 1
  • Persistent fever 1
  • Immunosuppression 1
  • Symptoms persist >14 days 5, 6
  • Suspected outbreak 1
  • Recent hospitalization or antibiotic use (consider C. difficile) 1

Stool Panel Should Include:

  • Bacterial culture (Salmonella, Shigella, Campylobacter, Yersinia) 1
  • Shiga toxin testing (or genes encoding them) to distinguish E. coli O157:H7 from other STEC 1
  • C. difficile toxin if recent healthcare exposure or antibiotics 1
  • Multiplex PCR panel for comprehensive pathogen detection 5

Obtain Blood Cultures If:

  • Infants <3 months 1
  • Signs of septicemia 1
  • Suspected enteric fever 1
  • Immunocompromised with systemic manifestations 1

Critical Pitfalls to Avoid

  • Never prioritize antimotility agents or antibiotics over rehydration – dehydration causes morbidity and mortality, not the diarrhea itself 2, 5
  • Never give antibiotics for bloody diarrhea until STEC is ruled out – obtain Shiga toxin testing first 1, 3
  • Never use loperamide when fever or bloody stools are present – risk of toxic megacolon 1, 2
  • Never prescribe empiric antibiotics for uncomplicated watery diarrhea – promotes resistance without benefit 1, 3, 2
  • Never use fluoroquinolones as first-line empiric therapy – >90% Campylobacter resistance in many regions 3
  • Never delay IV rehydration in severe dehydration while attempting oral rehydration 1, 2

Reassessment and Follow-Up

  • If no improvement within 48-72 hours, reassess for antibiotic resistance, fluid/electrolyte imbalances, non-infectious causes (IBS, IBD, bile acid malabsorption), and consider hospitalization 3, 5
  • Modify or discontinue antibiotics when specific pathogen identified 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Guideline Recommendations for Acute Watery Diarrhea in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Empiric Antibiotic Use in Diarrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Persistent Watery Diarrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Acute Diarrhea in Adults.

American family physician, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.